Media

Utilizing Change Management for Successful Implementation of Blue light cystoscopy (BLC™) - Rebecca Roe

Details
Rebecca Roe speaks to an interdisciplinary approach to implementation of Blue Light Cystoscopy (BLC™) in her community hospital center, giving a Clinical Education Program Coordinator's perspective. Her team engaged in the five management practices looking at ongoing communication and clinical training and measured things along the way, seeking feedback from every discipline that was utilized, whe...

Prostate Cancer Foundation's Women in Science Forum Discussion - Himisha Beltran, Lorelei Mucci, Karen Knudsen, and Amina Zoubeidi

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat 2019 (PCF 2019), Alicia Morgans is joined by the four women leaders and organizers of the Prostate Cancer Foundation's Women in Science Forum 2019. Himisha Beltran, Lorelei Mucci, Karen Knudsen, and Amina Zoubeidi each share their insights and motivations for leading the forum. Each of these professionals is moving the field forward...

Prostate 8 Program - Lifestyle, Exercise, and Nutrition - Stacey Kenfield

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat 2019 (PCF 2019), Stacey Kenfield joins Charles Ryan to speak about her work on lifestyle, exercise, nutrition and its impact on prostate cancer. She talks about the Prostate 8 program which resulted from looking at men with prostate cancer and studying different dietary and lifestyle factors that might be associated with prostate can...

The Biology of Prostate Cancer - Kenneth Pienta

Details
Kenneth Pienta joins Charles Ryan at the 26th Annual Prostate Cancer Foundation Scientific Retreat 2019 (PCF 2019) to discuss the biology of prostate cancer, and to share a clinician's perspective of thinking about the biology of this disease. This is a look at the current year and some of the significant findings that have changed the way we look at treating prostate cancer. The STAMPEDE data sho...

Immunotherapy and Chemotherapy Use in Patients with Metastatic Bladder Cancer - Ronac Mamtani and Ravi Parikh

Details
In this conversation, Ronac Mamtani and Ravi Parikh join Alicia Morgans to discuss their recent work on bladder cancer outcomes and effectiveness research. They discuss immune checkpoint therapy versus carboplatin chemotherapy in patients with metastatic urothelial cancer (mUC). They also discuss the "Association Between FDA Label Restriction and Immunotherapy and Chemotherapy Use in Bladder Cance...

Integrating PARP inhibitors into the Standard of Care for Prostate Cancer - Joaquin Mateo

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019), Joaquin Mateo, Principal Investigator, and Translational Scientist at the Vall d'Hebron hospital in Barcelona joins Charles Ryan to discuss how PARP inhibitors are being integrated into the standard of care for prostate cancer, pivotal studies that are reporting and ongoing with PARP inhibitors, and important aspect of th...

Antibody-drug conjugates for metastatic urothelial carcinoma & 177Lu-PSMA-617 for Progressive mCRPC - Scott Tagawa

Details
Scott Tagawa joins Alicia Morgans at the 26th Annual Prostate Cancer Foundation Scientific Retreat (PCF 2019) and discusses advances in bladder and prostate cancer. He highlights his recent work on antibody-drug conjugates (ADCs) in urothelial cancer and his presentation from ESMO on the initial results from TROPHY-U-01. Although immune checkpoint inhibitors now provide another option for patients...

"Eat, Move, Sleep" - June Chan

Details
At the 26th Annual Prostate Cancer Foundation Scientific Retreat 2019 (PCF 2019), Professor June Chan joins Charles Ryan to discuss her study "Eat, Move, Sleep," a digital cohort study that is focused on cancer survivorship aiming to collect data on diet, exercise, sleep, and other lifestyle practices in people with prostate, colorectal, and/or bladder cancer. This study is set to open in early 20...

Interpreting Phase III Clinical Trial Data - Susan Halabi

Details
During the 2019 Advanced Prostate Cancer Consensus Conference (APCCC 2019), Susan Halabi joined Alicia Morgans to help interpret the various ongoing stage III clinical trials in prostate cancer. Dr. Halabi shares the top errors we can avoid in subgroup analyses. Biographies: Susan Halabi, Ph.D., Professor of Biostatistics and Bioinformatics, Duke Cancer Institute, Durham, North Carolina, United St...

Evaluation of Cxbladder and Adjudication of Atypical Cytology and Equivocal Cystoscopy - Badrinath Konety

Details
Cxbladder diagnostic tests combine genomic information from urinary mRNA with phenotypic information to either rule out low-risk individuals or identify patients at a high risk of urothelial carcinoma (UC). In this video presentation, Badrinath Konety overviews this study which aimed to evaluate the performance of Cxbladder and urine cytology, and Cxbladder's adjudication of atypical cytology and...
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe